Circadian blood pressure variation in normotensive type 2 diabetes patients and angiotensin converting enzyme polymorphism

Diabetes Research and Clinical Practice

Volumn 80, Issue 3, 2008, Pages 386-391

  Czupryniak, Leszek ^a   Młynarski, Wojciech ^a   Pawłowski, Maciej ^a   Saryusz Wolska, Małgorzata ^a   Borkowska, Anna ^a   Klich, Izabela ^a   Bodalski, Jerzy ^a   Loba, Jerzy ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Angiotensin converting enzyme; Blood pressure; Diabetes mellitus; Endothelial dysfunction; Gene polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; BLOOD PRESSURE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; DIASTOLE; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REFERENCE VALUES; SEQUENCE DELETION; SYSTOLE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 43049168946     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.01.007     Document Type: Article

References (32)

1. Haffner S.M. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am. J. Cardiol. 97 2A (2006) 3A-11A
2. Stratton I.M., Cull C.A., Adler A.I., Matthews D.R., Neil H.A., and Holman R.R. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 49 (2006) 1761-1769
3. Nakano S., Fukuda M., Hotta F., Ito T., Ishii T., Kitazawa M., et al. Reversed circadian BP rhythm is associated with occurrences of both fatal and non-fatal vascular events in NIDDM subjects. Diabetes 7 (1998) 501-1506
4. Sturrock N.D., George E., Pound N., Stevenson J., Peck G.M., and Sowter H. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet. Med. 17 (2000) 360-364
5. Czupryniak L., Saryusz-Wolska M., Pawlowski M., and Loba J. Elevated systolic blood pressure is present in almost all individuals with newly diagnosed diabetes mellitus. J. Hum. Hypertension 20 (2006) 231-233
6. Czupryniak L., Wiśniewska-Jarosińska M., and Drzewoski J. Trandolapril restores circadian blood pressure variation in normoalbuminuric normotensive type 1 diabetic patients. J. Diabetes Compl. 15 (2001) 75-79
7. Czupryniak L., Strzelczyk J., Pawłowski M., and Loba J. Circadian blood pressure variation in morbidly obese hypertensive patients undergoing gastric bypass surgery. Am. J. Hypertens. 18 (2005) 446-451
8. Czupryniak L., Pawłowski M., Saryusz-Wolska M., and Loba J. Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients. Kidney Blood Press. Res. 30 (2007) 182-186
9. Vinik A.I., and Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 115 (2007) 387-397
10. Fukuda M., Goto N., and Kimura G. Hypothesis on renal mechanism of non-dipper pattern of circadian blood pressure rhythm. Med. Hypotheses 67 (2006) 802-806
11. Lurbe E., Redon J., Kesani A., Pascual J.M., Tacons J., Alvarez V., et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N. Engl. J. Med. 347 (2002) 797-805
12. Staessen J.A., Wang J.G., Ginocchio G., Petrov V., Saavedra A.P., Soubrier F., et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J. Hypertens. 15 12 Pt 2 (1997) 1579-1592
13. Krege J.H., Kim H.S., Moyer J.S., Jennette J.C., Peng L., Hiller S.K., et al. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 29 1 Pt 2 (1997) 150-157
14. Vinik A.I., Maser R.E., Mitchell B.D., and Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26 (2003) 1553-1579
15. O'Brien E., Coats A., Owens P., Petrie J., Padfield P.L., Littler W.A., et al. Use and interpretation of ambulatory BP monitoring: recommendations of the British Hypertension Society. BMJ 320 (2000) 1128-1134
16. The Scientific Committee: Consensus document on non-invasive ambulatory BP monitoring, J. Hypertens. 1990 8 (Suppl. 6) S135-S140.
17. O'Brien E., Asmar R., Beilin L., Imai Y., Mallion J.M., Mancia G., et al. On behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J. Hypertens. 21 (2003) 821-848
18. http://www.tufts.edu/∼mcourt01/Documents/Court%20lab%20-%20HW%20calculator.xls -; accessed 20 July 2007.
19. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86 (1990) 1343-1346
20. Danser A.H., Schalekamp M.A., Bax W.A., van den Brink A.M., Saxena P.R., Riegger G.A., et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92 (1995) 1387-1388
21. Sayed-Tabatabaei F.A., Oostra B.A., Isaacs A., van Duijn C.M., and Witteman J.C. ACE polymorphisms. Circ. Res. 98 (2006) 1123-1133
22. Hassler C., and Burnier M. Circadian variations in blood pressure: implications for chronotherapeutics. Am. J. Cardiovasc. Drugs 5 (2005) 7-15
23. Tikellis C., and Johnston C.I. Angiotensin-converting enzymes: properties and function. In: Oparil S., and Weber M.A. (Eds). Hypertension: A Companion to Brenner and Rector's The Kidney. second ed. (2005), Elsevier Saunders, Philadelphia, PA, USA 95-99
24. Huang W., Gallois Y., Bouby N., Bruneval P., Heudes D., Belair M.F., et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13330-13334
25. Ng D.P., Tai B.C., Koh D., Tan K.W., and Chia K.S. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 48 (2005) 1008-1016
26. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359 (1992) 641-644
27. Sayed-Tabatabaei F.A., Houwing-Duistermaat J.J., van Duijn C.M., and Witteman J.C. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis. Stroke 34 (2003) 1634-1639
28. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339 (1998) 229-234
29. Szadkowska A., Pietrzak I., Klich I., Mlynarski W., Bodalska-Lipinska J., and Bodalski J. Polymorphism I/D of the angiotensin-converting enzyme gene and disturbance of blood pressure in type 1 diabetic children and adolescents. Przegl Lek 63 Suppl. 3 (2006) 32-36
30. Jian M., Cao X., Huang J., Qi J., Liu G., Wang J., et al. Polymorphism of angiotensin I converting enzyme gene in the older Chinese: linked to ambulatory blood pressure levels and circadian blood pressure rhythm. Int. J. Cardiol. 55 (1996) 33-40
31. Vasku A., Soucek M., Hajek D., Holla L., Znojil V., and Vacha J. Association analysis of 24-h blood pressure records with I/D ACE gene polymorphism and ABO blood group system. Physiol. Res. 48 (1999) 99-104
32. Julve R., Chaves F.J., Rovira E., Pascual J.M., Miralles A., Armengod M.E., et al. Polymorphism insertion/deletion of the ACE gene and ambulatory blood pressure circadian variability in essential hypertension. Blood Press. Monit. 6 (2001) 27-32